Although HOX10 has been reported as an activator of canonical NF-κB signaling in pancreatic cancer cells (60), and although the antisense to HOXA11 (HOXA11-AS) was linked to protection of EC barrier function following injury (61), insight into the potential role of these genes in the EC TNF response is currently lacking. This evidence concerns the gene TNF and pancreatic neoplasm.